Effect of daily versus twice per day tamsulosin in management of ureteral stent symptoms among patients visiting a tertiary level hospital
Vol. 13 No. 1 (2024), Original Research Article
Vol. 13 No. 1 (2024)

Effect of daily versus twice per day tamsulosin in management of ureteral stent symptoms among patients visiting a tertiary level hospital

Original Research Article
Published 2024-03-21
Prajwal Paudyal
Kathmandu Medical College
Udaya Man Singh Dongol

Supplementary Files

PDF

Keywords

Key Words : USSQ score, 0.4 mg tamsulosin, 0.8 mg tamsulosin, stent related side effects

How to Cite

Paudyal, P., & Dongol, U. M. S. . (2024). Effect of daily versus twice per day tamsulosin in management of ureteral stent symptoms among patients visiting a tertiary level hospital. Journal of Kathmandu Medical College, 13(1), 3–6. Retrieved from https://jkmc.com.np/ojs3/index.php/journal/article/view/1357
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Introduction:  Currently, tamsulosin 0.4 mg daily is the dosage indicated for lower urinary tract symptoms for patients with an indwelling stent. In treating benign prostatic hyperplasia, a total maxim

References

Venkatesan N, Shroff S, Jayachandran K, Doble M. Polymers as ureteral stents. J Endourol. 2010; 24: 191-198. [PubMed | Full Text | DOI]

Dunn CJ, Matheson A, Faulds DM. Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs Aging. 2002;19(2):135-61. [PubMed | Full Text | DOI]

Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol. 2003 Mar;169(3):1060-4. [PubMed | Full Text | DOI]

Mirani KK, Ather MH. Translation and Validation of the Ureteral Stent Symptoms Questionnaire in Urdu. Cureus. 2022 Aug 8;14(8):e27764. [PubMed | Full Text | DOI]

Narayan P, Tewari A. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia. United States 93-01 Study Group. J Urol. 1998 Nov;160(5):1701-6. [PubMed | Full Text | DOI]

Navanimitkul N, Lojanapiwat B. Efficacy of tamsulosin 0.4 mg/day in relieving double-J stent-related symptoms: a randomized controlled study. J Int Med Res. 2010 Jul-Aug;38(4):1436-41. [PubMed | Full Text | DOI]

Liu Y, Chen Y, Liao B, Luo D, Wang K, Li H, Zeng G. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018 Oct;5(4):205-214.[PubMed | Full Text | DOI]

Van der Meer RW, Weltings S, van Erkel AR, Roshani H, Elzevier HW, van Dijk LC, et al. Antegrade ureteral stenting is a good alternative for the retrograde approach. Curr Urol 2016; 10(2): 87-91. [PubMed | Full Text | DOI]

Ahallal Y, Khallouk A, El Fassi MJ, Farih MH. Risk factor analysis and management of ureteral double-j stent complications. Rev Urol 2010; 12(2-3): e147-151. [PubMed | Full Text | DOI]

Paul CJ, Brooks NA, Ghareeb GM, Tracy CR. Pilot study to determine optimal stent duration following ureteroscopy: three versus seven days. Curr Urol 2017; 11(2): 97-102. [PubMed | Full Text | DOI]

Damiano R, Autorino R, De Sio M, Giacobbe A, Palumbo IM, D'Armiento M. et al. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol 2008; 22(4): 651-656. [PubMed | Full Text | DOI]

Lamb AD, Vowler SL, Johnston R, Dunn N, Wiseman OJ. Metaanalysis showing the beneficial effect of ?-blockers on ureteric stent discomfort. BJU Int 2011; 108(11): 1894-902. [PubMed | Full Text | DOI]

Yakoubi R, Lemdani M, Monga M, Villers A, Koenig P. Is there a role for ?-blockers in ureteral stent related symptoms? A systematic review and meta-analysis. J Urol 2011; 186(3): 928- 934. [PubMed | Full Text | DOI]

Osman T, Elawady H, Fawaz K, Shabayek M, Essam MD, Osman D, ElSaeed KO. Evaluation of Tamsulosin 0.4 mg versus 0.8 mg in management of lower urinary tract symptoms due to benign prostatic enlargement. Int Urol Nephrol. 2024 Jun;56(6):1811-1816. [PubMed | Full Text | DOI]